Company Filing History:
Years Active: 2010-2011
Title: Innovations of Baili Chen in Protein Kinase Modulation
Introduction
Baili Chen is a notable inventor based in Palo Alto, California, recognized for his contributions to the field of protein kinase modulation. With a total of two patents to his name, Chen's work focuses on developing compounds that can significantly impact cellular activities and therapeutic applications.
Latest Patents
Chen's latest patents include "Kinase modulators and methods of use" and "Protein kinase modulators and methods of use." The first patent relates to compounds that modulate protein kinase enzymatic activity, influencing cellular processes such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. These compounds specifically target kinases like p70S6 and Akt, providing methods for treating kinase-dependent diseases. The second patent emphasizes compounds that inhibit and regulate Checkpoint Kinases, particularly Checkpoint Kinase 1 (Chk1). This invention also outlines methods for treating cancer and other conditions associated with unwanted angiogenesis and cellular proliferation.
Career Highlights
Baili Chen is currently employed at Exelixis, Inc., where he continues to advance his research in the field of biotechnology. His innovative work has the potential to lead to significant breakthroughs in cancer treatment and other kinase-related diseases.
Collaborations
Chen collaborates with talented individuals such as Erick Wang Co and Larisa Dubenko, who contribute to the research and development of his innovative projects.
Conclusion
Baili Chen's contributions to the field of protein kinase modulation highlight the importance of innovation in medical research. His patents reflect a commitment to developing effective treatments for serious health conditions, showcasing the impact of his work on future therapeutic strategies.